We provided expert report and testimony for Migrata in an arbitration concerning a dispute over IP royalties in the pharmaceuticals sector.

Dr Edwards provided expert reports and testimony in the context of arbitration proceedings concerning an IP licensing agreement between Migrata and HemoCue in relation to technology for the testing of substances in fluids such as hemoglobin, and royalties claimed under that agreement.  Dr Edwards’ testimony included that there is nothing inherently anti-competitive about IP royalty obligations per se, the scope and post-patent nature of the royalty obligation in question or the nature of extensions to the royalty obligation as interpreted by Migrata.